Pfizer news
Pfizer Must Pay $6.3 Million in Damages Over Prempro
Pfizer Must Pay $6.3 Million in Damages Over Prempro
Bloomberg - 1 hour ago
By Sophia Pearson and Jef Feeley Nov. 20 (Bloomberg) -- Two Pfizer Inc. units' hormone- replacement therapy drugs Prempro and Provera caused an Illinois woman's breast cancer, making them liable ...
Direction Of Health Overhaul Helps US Drug Stocks >MRK PFE
Direction Of Health Overhaul Helps US Drug Stocks >MRK PFE
Wall Street Journal - 50 minutes ago
By Peter Loftus Of DOW JONES NEWSWIRES Several US pharmaceutical stocks rose Friday as Pfizer Inc. (PFE) and Merck & Co. (MRK) hit 52-week highs, partly due to increasing investor comfort that a ...
Pfizer Units Must Pay $6.3 Million in Prempro Case
Pfizer Units Must Pay $6.3 Million in Prempro Case
Bloomberg - 12 minutes ago
By Sophia Pearson and Jef Feeley Nov. 20 (Bloomberg) -- Two Pfizer Inc. units' hormone- replacement therapy drugs Prempro and Provera caused an Illinois woman's breast cancer and are liable for at ...
Pfizer Receives FDA Approval For Geodon (Ziprasidone HCI) Capsules For The Adjunctive Maintenance Treatment Of Bipolar Disorder In Adults
Pfizer Receives FDA Approval For Geodon (Ziprasidone HCI) Capsules For The Adjunctive Maintenance Treatment Of Bipolar Disorder In Adults
Reuters Key Development - 47 minutes ago
New 52-Week High Stocks (NLST, PFE, TRA, SJM, DBRN)
New 52-Week High Stocks (NLST, PFE, TRA, SJM, DBRN)
Benzinga - 48 minutes ago
Netlist, Inc. (NASDAQ: NLST) hits a new 52-week high at $7.80 in today's morning trade. Currently NLST is trading at $7.42, up 31%. In the past one month, the stock is up over 1090%. Pfizer Inc ...
Antitrust Lawyer Files Suit to Stop Pfizer Merger
Antitrust Lawyer Files Suit to Stop Pfizer Merger
PharmaLive - 23 minutes ago
Nov. 20--A prominent San Francisco antitrust attorney said Thursday he has filed a request in federal court for a temporary restraining order against Pfizer Inc. to try to roll back its merger ...
FDA Approves Intravenous Formulation Of Pfizer's Revatio (Sildenafil) For Treatment Of Pulmonary Arterial Hypertension
FDA Approves Intravenous Formulation Of Pfizer's Revatio (Sildenafil) For Treatment Of Pulmonary Arterial Hypertension
Reuters Key Development - 35 minutes ago
